A New Prognostic Score Supporting Treatment Allocation for Multimodality Therapy for Malignant Pleural Mesothelioma
- 1 November 2015
- journal article
- review article
- Published by Elsevier in Journal of Thoracic Oncology
- Vol. 10 (11) , 1634-1641
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Biostatistics Primer: What a Clinician Ought to Know—Prognostic and Predictive FactorsJournal of Thoracic Oncology, 2013
- Volumetry: an alternative to assess therapy response for malignant pleural mesothelioma?European Respiratory Journal, 2011
- Multicenter Phase II Trial of Neoadjuvant Pemetrexed Plus Cisplatin Followed by Extrapleural Pneumonectomy and Radiation for Malignant Pleural MesotheliomaJournal of Clinical Oncology, 2009
- Trimodality Therapy With Induction Chemotherapy Followed by Extrapleural Pneumonectomy and Adjuvant High-Dose Hemithoracic Radiation for Malignant Pleural MesotheliomaJournal of Clinical Oncology, 2009
- Multicenter trial of neo-adjuvant chemotherapy followed by extrapleural pneumonectomy in malignant pleural mesotheliomaAnnals of Oncology, 2007
- Statistical Validation of the EORTC Prognostic Model for Malignant Pleural Mesothelioma Based on Three Consecutive Phase II TrialsJournal of Clinical Oncology, 2005
- Neoadjuvant Chemotherapy Followed by Extrapleural Pneumonectomy in Malignant Pleural MesotheliomaJournal of Clinical Oncology, 2004
- Modified RECIST criteria for assessment of response in malignant pleural mesotheliomaAnnals of Oncology, 2004
- Extrapleural Pneumonectomy in the Multimodality Therapy of Malignant Pleural MesotheliomaAnnals of Surgery, 1996
- The importance of surgical staging in the treatment of malignant pleural mesotheliomaThe Journal of Thoracic and Cardiovascular Surgery, 1996